AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Meridian announces manufacturing agreement with Hawaii Biotech.

Vaccine Weekly

| July 09, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 JUL 9 - (NewsRx.com & NewsRx.net) -- Meridian Bioscience, Inc., (VIVO) announced the signing of its second biopharmaceutical manufacturing agreement for the company's life-science production facility located at Viral Antigens, Inc., Memphis, Tennesee (VAI), a wholly owned subsidiary.

Hawaii Biotech, Inc., has selected VAI to manufacture and supply bulk polyvalent recombinant subunit vaccine for dengue virus 1-4.

The bulk vaccine for human clinical studies will be produced in VAI's new facility designed for the production of recombinant proteins and antibodies for use in therapeutic agents and vaccines.

Hawaii Biotech has developed its dengue vaccine using proprietary technology based on the production of recombinant antigens from the Drosophila cell expression system. The vaccine has been developed in order to confer protective immunity in humans to all four dengue viruses simultaneously. Any of the four viruses can cause dengue fever; however, immunity to less than all four increases the ...

Related articles from newspapers, magazines, journals, and more
Meridian Bioscience Announces Exchange Offer for and Plans to Redeem 7%...
Press release article from: Business Wire November 12, 2003 700+ words
...BUSINESS WIRE)--Nov. 12, 2003 Meridian Bioscience, Inc., Cincinnati, Ohio (Nasdaq...will be due on September 1, 2013. Meridian Bioscience may prepay the new debentures at...convertible into common shares of Meridian Bioscience at anytime at a conversion price...
Meridian Bioscience Wins GHX 2009 Best in Class Award.
Newspaper article from: Cardiovascular Week June 22, 2009 700+ words
Meridian Bioscience (NASDAQ: VIVO) announced that it is a recipient of...product category for the 2008 calendar year (see also Meridian Bioscience). Meridian Bioscience was among the 30 leading medical-surgical product...
Meridian Bioscience Announces New Exclusive Canadian Distribution Agreement...
Newspaper article from: Gastroenterology Week September 22, 2008 700+ words
Meridian Bioscience, Inc., Cincinnati, Ohio...non-US businesses (see also Meridian Bioscience, Inc.). Somagen Diagnostics...Chief Executive Officer, Meridian Bioscience commented, "The effective...
Meridian Bioscience, Inc. - Financial and Strategic Analysis Review.
Press release article from: M2 Presswire April 30, 2009 700+ words
...companiesandmarkets.com: Meridian Bioscience, Inc. - Financial and Strategic...companiesandmarkets.com adds new report: Meridian Bioscience, Inc. - Financial and Strategic Analysis Review Meridian Bioscience, Inc. - Financial and Strategic...
Meridian Bioscience Europe Announces Agreement to Distribute Test for GI...
Newspaper article from: Gastroenterology Week October 12, 2009 700+ words
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) announced that Meridian Bioscience Europe srl, Milan, Italy has signed...patients and health systems (see also Meridian Bioscience, Inc.). Antonio Interno, President...
Boston, MA -- Form4Oracle: Insider Trading Report: Meridian Bioscience Inc...
Press release article from: M2 Presswire April 22, 2009 700+ words
...Form4Oracle: Insider Trading Report: Meridian Bioscience Inc (VIVO)(C)1994-2009 M2...Exec VP, Operations & IS at Meridian Bioscience Inc (VIVO) has reported buying...Exec VP, Operations & IS in Meridian Bioscience Inc by 66%.For a current, real...
The Bellwether Report notices the potential in Meridian Bioscience Inc.
Press release article from: M2 Presswire January 25, 2006 700+ words
...Report notices the potential in Meridian Bioscience Inc(C)1994-2006 M2 COMMUNICATIONS...Bellwether Report has identified Meridian Bioscience Inc. (NASDAQ:VIVO), a company...free 30 day no obligation trial. Meridian Bioscience Inc. is a fully integrated life...
Meridian Bioscience Announces Final Redemption of its 5% Convertible...
Press release article from: Business Wire January 30, 2007 700+ words
CINCINNATI -- Meridian Bioscience, Inc., Cincinnati, Ohio...shares of common stock of Meridian Bioscience at a conversion price of...Debentures into common stock of Meridian Bioscience will expire at close of business...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA